• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number NR7TCSIY
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Cardiac Tamponade (2226)
Event Date 05/19/2022
Event Type  Injury  
Manufacturer Narrative
Device investigation details: available information indicates that the device is not available for return, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A device history record evaluation was performed for the finished device 30740341m number, and no internal action related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Event Description
It was reported that a (b)(6) year-old male patient ((b)(6) kg) underwent a cardiac ablation procedure with a navistar® rmt thermocool® electrophysiology catheter and the patient suffered cardiac tamponade requiring a pericardiocentesis, surgical intervention and prolonged hospitalization.The cardiac tamponade was noticed right after procedure.The procedure has been successfully completed.The patient required surgery for the cardiac tamponade.The physician¿s opinion on the cause of this adverse event is that it was procedure related.Draining from epicardial space was also performed.The patient outcome of the adverse event was improved.The patient required extended hospitalization because of the adverse event.Activated clotting time (act) range was 257-306 during the procedure.Heparin 12000 iu after transseptal, total 23000 iu during procedure.A smartablate generator was used during this case.A transseptal puncture was performed with an abbott brk-1, 407201.There was no evidence of steam pop.The irrigated catheter flow setting was set to 2/17 ml.The correct catheter settings were selected on the smartablate generator and the pump switching from low to high flow during ablation.
 
Manufacturer Narrative
On 8-jul-2022, additional information was received which indicated pericardium puncture was performed to drain the pericardial space; no open-heart surgery.Based on this new information, please consider the 6.Health effect - impact code of ¿surgical interventions¿ (f19) to be removed.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NAVISTAR® RMT THERMOCOOL® ELECTROPHYSIOLOGY CATHETER
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key14684195
MDR Text Key294922035
Report Number2029046-2022-01292
Device Sequence Number1
Product Code OAD
UDI-Device Identifier10846835008500
UDI-Public10846835008500
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
P030031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNR7TCSIY
Device Catalogue NumberNR7TCSIY
Device Lot Number30740341M
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/19/2022
Initial Date FDA Received06/14/2022
Supplement Dates Manufacturer Received07/08/2022
Supplement Dates FDA Received07/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
ABBOTT BRK-1; CARTO 3 SYSTEM; SMARTABLATE GENERATOR KIT-WW; SOUNDSTAR ECO GE 8F CATHETER; UNKNOWN PUMP
Patient Outcome(s) Required Intervention; Life Threatening; Hospitalization;
Patient Age69 YR
Patient SexMale
Patient Weight120 KG
-
-